Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.04
GNC's Cash to Debt is ranked lower than
95% of the 372 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.65 vs. GNC: 0.04 )
Ranked among companies with meaningful Cash to Debt only.
GNC' s Cash to Debt Range Over the Past 10 Years
Min: 0.04  Med: 0.14 Max: N/A
Current: 0.04
Equity to Asset 0.11
GNC's Equity to Asset is ranked lower than
95% of the 370 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.43 vs. GNC: 0.11 )
Ranked among companies with meaningful Equity to Asset only.
GNC' s Equity to Asset Range Over the Past 10 Years
Min: 0.11  Med: 0.29 Max: 0.42
Current: 0.11
0.11
0.42
Interest Coverage 9.62
GNC's Interest Coverage is ranked lower than
60% of the 308 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.42 vs. GNC: 9.62 )
Ranked among companies with meaningful Interest Coverage only.
GNC' s Interest Coverage Range Over the Past 10 Years
Min: 2.02  Med: 6.40 Max: 10.74
Current: 9.62
2.02
10.74
F-Score: 5
Z-Score: 2.76
M-Score: -2.87
WACC vs ROIC
4.40%
12.89%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 14.31
GNC's Operating margin (%) is ranked higher than
95% of the 372 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.79 vs. GNC: 14.31 )
Ranked among companies with meaningful Operating margin (%) only.
GNC' s Operating margin (%) Range Over the Past 10 Years
Min: 10.24  Med: 14.26 Max: 17.61
Current: 14.31
10.24
17.61
Net-margin (%) 7.84
GNC's Net-margin (%) is ranked higher than
93% of the 373 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.75 vs. GNC: 7.84 )
Ranked among companies with meaningful Net-margin (%) only.
GNC' s Net-margin (%) Range Over the Past 10 Years
Min: 3.3  Med: 7.35 Max: 10.08
Current: 7.84
3.3
10.08
ROE (%) 36.60
GNC's ROE (%) is ranked higher than
95% of the 365 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 8.68 vs. GNC: 36.60 )
Ranked among companies with meaningful ROE (%) only.
GNC' s ROE (%) Range Over the Past 10 Years
Min: 5.78  Med: 22.62 Max: 35.82
Current: 36.6
5.78
35.82
ROA (%) 7.89
GNC's ROA (%) is ranked higher than
82% of the 374 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.20 vs. GNC: 7.89 )
Ranked among companies with meaningful ROA (%) only.
GNC' s ROA (%) Range Over the Past 10 Years
Min: 2.38  Med: 6.92 Max: 10.02
Current: 7.89
2.38
10.02
ROC (Joel Greenblatt) (%) 54.85
GNC's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 372 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.66 vs. GNC: 54.85 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
GNC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 35.42  Med: 54.05 Max: 73.51
Current: 54.85
35.42
73.51
Revenue Growth (3Y)(%) 10.60
GNC's Revenue Growth (3Y)(%) is ranked higher than
77% of the 321 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.00 vs. GNC: 10.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
GNC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 10.60 Max: 16.1
Current: 10.6
0
16.1
EBITDA Growth (3Y)(%) 5.60
GNC's EBITDA Growth (3Y)(%) is ranked higher than
54% of the 287 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.50 vs. GNC: 5.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
GNC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 19.50 Max: 28
Current: 5.6
0
28
EPS Growth (3Y)(%) 4.40
GNC's EPS Growth (3Y)(%) is ranked lower than
53% of the 245 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.10 vs. GNC: 4.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
GNC' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 31.40 Max: 58.1
Current: 4.4
0
58.1
» GNC's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-07-30)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

GNC Guru Trades in Q2 2015

Joel Greenblatt 519,395 sh (+13.37%)
RS Investment Management 646,013 sh (+6.04%)
Steven Cohen Sold Out
Mario Gabelli 6,780 sh (-0.59%)
Private Capital 407,574 sh (-0.61%)
Jim Simons 308,300 sh (-43.32%)
Richard Snow 6,500 sh (-45.38%)
» More
Q3 2015

GNC Guru Trades in Q3 2015

Paul Tudor Jones 6,644 sh (New)
John Hussman 100,000 sh (New)
Jim Simons 907,890 sh (+194.48%)
Joel Greenblatt 1,302,540 sh (+150.78%)
Mario Gabelli 6,780 sh (unchged)
Richard Snow Sold Out
Private Capital 404,644 sh (-0.72%)
RS Investment Management 430,583 sh (-33.35%)
» More
Q4 2015

GNC Guru Trades in Q4 2015

Steven Cohen 769,800 sh (New)
Louis Moore Bacon 500,000 sh (New)
Joel Greenblatt 1,919,705 sh (+47.38%)
Mario Gabelli 7,100 sh (+4.72%)
Private Capital 407,864 sh (+0.80%)
John Hussman Sold Out
Paul Tudor Jones Sold Out
RS Investment Management Sold Out
Jim Simons 433,580 sh (-52.24%)
» More
Q1 2016

GNC Guru Trades in Q1 2016

Mario Gabelli 8,300 sh (+16.90%)
Louis Moore Bacon Sold Out
Private Capital 401,972 sh (-1.44%)
Steven Cohen 545,333 sh (-29.16%)
Jim Simons 205,900 sh (-52.51%)
Joel Greenblatt 281,725 sh (-85.32%)
» More
» Details

Insider Trades

Latest Guru Trades with GNC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare:TSE:3398, TSE:9627, SZSE:002727, JSE:CLS, TSE:3148 » details
Traded in other countries:IGN.Germany,
GNC Holdings Inc is a specialty retailer of health, wellness and performance products, including vitamins, minerals and herbal supplement products (VMHS), sports nutrition products and diet products.

GNC Holdings Inc was founded in 1935. It is a specialty retailer of health and wellness products, including VMHS products, sports nutrition products, and diet products. The Company's business segments include: Retail, Franchising and Manufacturing/Wholesale. Its retail segment is engaged in sales of products to customers at its company-owned stores in the United States, Canada and Puerto Rico and through its websites, GNC.com, LuckyVitamin.com and DiscountSupplements.com. As of December 31, 2013, the Company operated 3,342 company-owned stores across all 50 states including the District of Columbia, Canada and Puerto Rico. Its franchise segment consists of its domestic and international franchise operations, and engaged in franchise activities mainly product sales to franchisees, royalties on franchise retail sales and franchise fees. As of December 31, 2013, there were 3,036 franchise stores operating, including 1,012 stores in the U.S. and 2,024 international franchise stores operating in over 50 international countries. Its franchise stores in the United States offer both its proprietary products and third-party products, with a product selection similar to that of its company-owned stores. Its international franchise stores are offered a more limited product selection than its franchise stores in the United States with the product selection heavily weighted toward proprietary products. Manufacturing/Wholesale segment consists of manufacturing operations in South Carolina and its wholesale sales business. This segment supplies its Retail and Franchise segments as well as various third parties with finished products. Its Manufacturing/Wholesale segment is engaged in sales of manufactured products to third parties, and the sale of its proprietary and third-party brand products to Rite Aid, Sam's Club, PetSmart and www.drugstore.com. Its wholesale operations are supported mainly by its Anderson, South Carolina distribution center. The Company's sales are in four major nutritional supplement categories: VMHS, sports nutrition, diet and other wellness. It offers high-quality nutritional supplements sold under its GNC proprietary brand names, including Mega Men, Ultra Mega, Total LeanTM, Pro Performance and Pro Performance AMP, Beyond Raw and under nationally recognized third-party brand names. Its online channels are, GNC.com, LuckyVitamin.com and DiscountSupplements.com. It competes with other specialty retailers, supermarkets, drugstores, mass merchants, multi-level marketing organizations, mail-order companies, other internet sites and a variety of other smaller participants. The Company is subject to also subject to regulation under various national, local and international laws.

Ratios

vs
industry
vs
history
P/E(ttm) 9.80
GNC's P/E(ttm) is ranked higher than
89% of the 318 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.83 vs. GNC: 9.80 )
Ranked among companies with meaningful P/E(ttm) only.
GNC' s P/E(ttm) Range Over the Past 10 Years
Min: 9.5  Med: 17.16 Max: 31.9
Current: 9.8
9.5
31.9
Forward P/E 7.91
GNC's Forward P/E is ranked higher than
96% of the 78 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 17.39 vs. GNC: 7.91 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 9.80
GNC's PE(NRI) is ranked higher than
89% of the 303 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.83 vs. GNC: 9.80 )
Ranked among companies with meaningful PE(NRI) only.
GNC' s PE(NRI) Range Over the Past 10 Years
Min: 9.52  Med: 17.19 Max: 31.9
Current: 9.8
9.52
31.9
Price/Owner Earnings (ttm) 6.23
GNC's Price/Owner Earnings (ttm) is ranked higher than
88% of the 190 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 21.05 vs. GNC: 6.23 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
GNC' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 6.07  Med: 14.66 Max: 21.29
Current: 6.23
6.07
21.29
P/B 5.93
GNC's P/B is ranked lower than
92% of the 377 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.81 vs. GNC: 5.93 )
Ranked among companies with meaningful P/B only.
GNC' s P/B Range Over the Past 10 Years
Min: 2.17  Med: 4.72 Max: 8.2
Current: 5.93
2.17
8.2
P/S 0.78
GNC's P/S is ranked lower than
66% of the 381 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.48 vs. GNC: 0.78 )
Ranked among companies with meaningful P/S only.
GNC' s P/S Range Over the Past 10 Years
Min: 0.75  Med: 1.56 Max: 2.32
Current: 0.78
0.75
2.32
PFCF 6.02
GNC's PFCF is ranked higher than
90% of the 162 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 17.91 vs. GNC: 6.02 )
Ranked among companies with meaningful PFCF only.
GNC' s PFCF Range Over the Past 10 Years
Min: 5.86  Med: 19.87 Max: 34.38
Current: 6.02
5.86
34.38
POCF 5.26
GNC's POCF is ranked higher than
82% of the 208 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 10.48 vs. GNC: 5.26 )
Ranked among companies with meaningful POCF only.
GNC' s POCF Range Over the Past 10 Years
Min: 5.13  Med: 15.67 Max: 25.08
Current: 5.26
5.13
25.08
EV-to-EBIT 8.51
GNC's EV-to-EBIT is ranked higher than
82% of the 315 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.98 vs. GNC: 8.51 )
Ranked among companies with meaningful EV-to-EBIT only.
GNC' s EV-to-EBIT Range Over the Past 10 Years
Min: 8.46  Med: 12.30 Max: 16.5
Current: 8.51
8.46
16.5
EV-to-EBITDA 7.39
GNC's EV-to-EBITDA is ranked higher than
77% of the 325 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 11.10 vs. GNC: 7.39 )
Ranked among companies with meaningful EV-to-EBITDA only.
GNC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.36  Med: 10.85 Max: 14.3
Current: 7.39
7.36
14.3
PEG 0.57
GNC's PEG is ranked higher than
95% of the 164 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.28 vs. GNC: 0.57 )
Ranked among companies with meaningful PEG only.
GNC' s PEG Range Over the Past 10 Years
Min: 0.46  Med: 0.69 Max: 1
Current: 0.57
0.46
1
Current Ratio 2.21
GNC's Current Ratio is ranked higher than
86% of the 355 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.19 vs. GNC: 2.21 )
Ranked among companies with meaningful Current Ratio only.
GNC' s Current Ratio Range Over the Past 10 Years
Min: 2.21  Med: 3.11 Max: 3.91
Current: 2.21
2.21
3.91
Quick Ratio 0.68
GNC's Quick Ratio is ranked lower than
55% of the 355 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.74 vs. GNC: 0.68 )
Ranked among companies with meaningful Quick Ratio only.
GNC' s Quick Ratio Range Over the Past 10 Years
Min: 0.68  Med: 1.23 Max: 1.85
Current: 0.68
0.68
1.85
Days Inventory 122.28
GNC's Days Inventory is ranked lower than
93% of the 358 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 40.35 vs. GNC: 122.28 )
Ranked among companies with meaningful Days Inventory only.
GNC' s Days Inventory Range Over the Past 10 Years
Min: 111.33  Med: 118.20 Max: 124.85
Current: 122.28
111.33
124.85
Days Sales Outstanding 17.56
GNC's Days Sales Outstanding is ranked lower than
54% of the 289 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 13.88 vs. GNC: 17.56 )
Ranked among companies with meaningful Days Sales Outstanding only.
GNC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 19.05  Med: 19.67 Max: 20.17
Current: 17.56
19.05
20.17
Days Payable 45.69
GNC's Days Payable is ranked higher than
50% of the 296 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 45.66 vs. GNC: 45.69 )
Ranked among companies with meaningful Days Payable only.
GNC' s Days Payable Range Over the Past 10 Years
Min: 28.85  Med: 30.94 Max: 41.66
Current: 45.69
28.85
41.66

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.96
GNC's Dividend Yield is ranked higher than
72% of the 452 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.83 vs. GNC: 2.96 )
Ranked among companies with meaningful Dividend Yield only.
GNC' s Dividend Yield Range Over the Past 10 Years
Min: 0.27  Med: 1.35 Max: 3.04
Current: 2.96
0.27
3.04
Dividend Payout 0.29
GNC's Dividend Payout is ranked higher than
70% of the 267 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.35 vs. GNC: 0.29 )
Ranked among companies with meaningful Dividend Payout only.
GNC' s Dividend Payout Range Over the Past 10 Years
Min: 0.18  Med: 0.23 Max: 0.33
Current: 0.29
0.18
0.33
Dividend Growth (3y) 17.80
GNC's Dividend Growth (3y) is ranked higher than
82% of the 179 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.30 vs. GNC: 17.80 )
Ranked among companies with meaningful Dividend Growth (3y) only.
GNC' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 17.8
Current: 17.8
0
17.8
Forward Dividend Yield 3.23
GNC's Forward Dividend Yield is ranked higher than
72% of the 424 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.95 vs. GNC: 3.23 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 2.96
GNC's Yield on cost (5-Year) is ranked higher than
50% of the 464 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.92 vs. GNC: 2.96 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
GNC' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.27  Med: 1.35 Max: 3.04
Current: 2.96
0.27
3.04
3-Year Average Share Buyback Ratio 8.40
GNC's 3-Year Average Share Buyback Ratio is ranked higher than
98% of the 200 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: -0.70 vs. GNC: 8.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
GNC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4.1  Med: 5.60 Max: 0
Current: 8.4
-4.1
0

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.57
GNC's Price/Projected FCF is ranked higher than
85% of the 220 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.44 vs. GNC: 0.57 )
Ranked among companies with meaningful Price/Projected FCF only.
GNC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.72  Med: 1.04 Max: 1.97
Current: 0.57
0.72
1.97
Price/Median PS Value 0.50
GNC's Price/Median PS Value is ranked higher than
92% of the 344 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.07 vs. GNC: 0.50 )
Ranked among companies with meaningful Price/Median PS Value only.
GNC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.63  Med: 1.00 Max: 1.4
Current: 0.5
0.63
1.4
Price/Peter Lynch Fair Value 0.64
GNC's Price/Peter Lynch Fair Value is ranked higher than
91% of the 98 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.72 vs. GNC: 0.64 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
GNC' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.67  Med: 0.76 Max: 0.87
Current: 0.64
0.67
0.87
Earnings Yield (Greenblatt) (%) 11.75
GNC's Earnings Yield (Greenblatt) (%) is ranked higher than
85% of the 382 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.60 vs. GNC: 11.75 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
GNC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 6.1  Med: 8.10 Max: 11.83
Current: 11.75
6.1
11.83
Forward Rate of Return (Yacktman) (%) 24.94
GNC's Forward Rate of Return (Yacktman) (%) is ranked higher than
87% of the 227 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 7.33 vs. GNC: 24.94 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
GNC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 22  Med: 24.40 Max: 36.9
Current: 24.94
22
36.9

More Statistics

Revenue (TTM) (Mil) $2,638
EPS (TTM) $ 2.56
Beta0.56
Short Percentage of Float8.06%
52-Week Range $22.64 - 51.69
Shares Outstanding (Mil)68.37

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 2,654 2,681 2,797
EPS ($) 2.98 3.13 3.50
EPS without NRI ($) 2.98 3.13 3.50
EPS Growth Rate
(3Y to 5Y Estimate)
8.00%
» More Articles for GNC

Headlines

Articles On GuruFocus.com
Lessons From Valeant Mar 22 2016 
Private Capital Reduces Holdings in Healthcare Stocks Dec 18 2014 
Why GNC Holdings Is a Good Buy Despite a Mixed Quarter Nov 30 2014 
Why Investors Should Expect a Turnaround at GNC Holdings Nov 18 2014 
These Health Retailers Are Enticing Long-Term Bets Aug 06 2014 
GNC Could Generate a 55% Return May 08 2014 
Herbalife and GNC Are Good Investments, Here’s Why Apr 17 2014 
Top 5 Stocks from TPG-Axon Mar 21 2013 
Billionaire Steven Cohen Vitamins Up with GNC Mar 04 2013 
Generac Holdings: Umbrellas Sell Better on and After Rainy Days Nov 28 2012 

More From Other Websites
GNC HOLDINGS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 24 2016
Transactions in relation to share buyback program May 24 2016
Greencore Group Plc :GNC-GB: Earnings Analysis: For the six months ended March 31, 2016 : May 23,... May 23 2016
GrainCorp Ltd. :GNC-AU: Earnings Analysis: For the six months ended March 31, 2016 : May 18, 2016 May 18 2016
How Did GNC Holdings’ Segments Fare in 1Q16? May 18 2016
GN ReSound has signed a supply agreement with Audigy Group and entered into a contingent agreement... May 17 2016
Transactions in relation to share buyback program May 15 2016
Hagens Berman Continues Investigation of Mislabeled “Dietary Supplements” Promoting Weight Loss,... May 10 2016
Interim Report Q1 2016: Strong revenue growth of 15% in GN ReSound and 9% in GN Netcom CC&O May 10 2016
Coverage initiated on GNC Holdings by Piper Jaffray May 10 2016
GNC HOLDINGS, INC. Financials May 05 2016
ETF’s with exposure to GNC Holdings, Inc. : May 4, 2016 May 04 2016
How Did GNC Holdings’ 1Q16 Earnings Turn Out? May 04 2016
Transactions in relation to share buyback program May 04 2016
GNC Eyes a Sale, but Would Anyone Want to Buy It? May 03 2016
GNC Holdings, Inc. :GNC-US: Earnings Analysis: Q1, 2016 By the Numbers May 03 2016
GNC says it's considering sale of company May 03 2016
8 Stocks Spiking on Big Volume May 03 2016
Total number of voting rights and share capital in GN Store Nord A/S May 03 2016
[$$] GNC Holdings Considering Selling Itself May 02 2016
[$$] GNC Considers Sale of Company May 02 2016
GNC Gains as Nutrition Company May Sell Itself, Restructure May 02 2016
GNC Considers Putting Itself Up For Sale May 02 2016
GNC Weighs Selling Itself -- Who Should Buy It? May 02 2016
New Strong Sell Stocks for May 2nd May 02 2016
GNC shares jump after company says it's considering sale May 02 2016
GNC Commences Strategic And Financial Review To Increase Shareholder Value May 02 2016
GNC Commences Strategic And Financial Review To Increase Shareholder Value May 02 2016
Transactions in relation to share buyback program Apr 29 2016
GNC misses Street 1Q forecasts Apr 28 2016
GNC Holdings, Inc. Reports First Quarter 2016 Results Apr 28 2016
GNC Holdings, Inc. Announces Quarterly Dividend Apr 27 2016
Transactions in relation to share buyback program Apr 26 2016
Addressing the true needs of hearing aid users: Smarter Fitting Apr 19 2016
Transactions in relation to share buyback program Apr 18 2016
GNC Holdings, Inc. First Quarter 2016 Earnings Release, Webcast and Conference Call Scheduled for... Apr 14 2016
Reduction of GN Store Nord’s share capital Apr 12 2016
Transactions in relation to share buyback program Apr 08 2016
Transactions in relation to share buyback program Apr 05 2016
GN Store Nord issues warrants to the executive management and key employees Mar 29 2016
Transactions in relation to share buyback program Mar 23 2016
Transactions in relation to share buyback program Mar 22 2016
GNC beats 4Q profit forecasts Feb 11 2016
Dietary aid shares sink as US moves against small producers Nov 17 2015
Dietary supplement shares dive on DOJ action Nov 17 2015
GNC misses Street 3Q forecasts Oct 29 2015
GNC misses Street 2Q forecasts Jul 30 2015
GNC misses Street 1Q forecasts Apr 30 2015
GNC reaches deal with NY AG over Herbal Plus products Mar 30 2015
GNC beats Street 4Q forecasts Feb 12 2015
GNC beats 3Q profit forecasts Oct 30 2014
Exclusive- Vitamin Shoppe in talks to hire bank amid activist pressure: sources Oct 20 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)